These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 13680840

  • 21. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2.
    Gierse JK, Staten NR, Casperson GF, Koboldt CM, Trigg JS, Reitz BA, Pierce JL, Seibert K.
    Vet Ther; 2002; 3(3):270-80. PubMed ID: 12447834
    [Abstract] [Full Text] [Related]

  • 22. Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
    Hsu N, Cai D, Damodaran K, Gomez RF, Keck JG, Laborde E, Lum RT, Macke TJ, Martin G, Schow SR, Simon RJ, Villar HO, Wick MM, Beroza P.
    J Med Chem; 2004 Sep 23; 47(20):4875-80. PubMed ID: 15369391
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system.
    Santagati A, Granata G, Marrazzo A, Santagati M.
    Arch Pharm (Weinheim); 2003 Sep 23; 336(9):429-35. PubMed ID: 14528491
    [Abstract] [Full Text] [Related]

  • 24. Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses.
    Kim SY, Moon TC, Chang HW, Son KH, Kang SS, Kim HP.
    Phytother Res; 2002 Nov 23; 16(7):616-20. PubMed ID: 12410540
    [Abstract] [Full Text] [Related]

  • 25. COX-2 inhibition: not too hot, not too cold--(perhaps) just right?
    Bakowsky V, Hanly JG.
    J Rheumatol; 2000 Dec 23; 27(12):2734-7. PubMed ID: 11128655
    [No Abstract] [Full Text] [Related]

  • 26. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA, Warner TD, Vojnovic I, Del Soldato P, Parikh A, Scadding GK, Mitchell JA.
    Br J Pharmacol; 2002 Dec 23; 137(7):1031-8. PubMed ID: 12429575
    [Abstract] [Full Text] [Related]

  • 27. COX-2 inhibitors--is there cause for concern?
    Seibert K, Lefkowith J, Tripp C, Isakson P, Needleman P.
    Nat Med; 1999 Jun 23; 5(6):621-2. PubMed ID: 10371498
    [No Abstract] [Full Text] [Related]

  • 28. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Praveen Rao PN, Amini M, Li H, Habeeb AG, Knaus EE.
    J Med Chem; 2003 Nov 06; 46(23):4872-82. PubMed ID: 14584938
    [Abstract] [Full Text] [Related]

  • 29. (-)-Epiafzelechin: cyclooxygenase-1 inhibitor and anti-inflammatory agent from aerial parts of Celastrus orbiculatus.
    Min KR, Hwang BY, Lim HS, Kang BS, Oh GJ, Lee J, Kang SH, Lee KS, Ro JS, Kim Y.
    Planta Med; 1999 Jun 06; 65(5):460-2. PubMed ID: 10418338
    [Abstract] [Full Text] [Related]

  • 30. Dual inhibition of cyclooxygenase-1 and 5-lipoxygenase by aerial part of Bupleurum fruticescens methanol extract.
    Prieto JM, Giner RM, Recio MC, Máñez S, Ríos JL.
    Fitoterapia; 2004 Mar 06; 75(2):179-86. PubMed ID: 15030922
    [Abstract] [Full Text] [Related]

  • 31. Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri.
    Likhitwitayawuid K, Sawasdee K, Kirtikara K.
    Planta Med; 2002 Sep 06; 68(9):841-3. PubMed ID: 12357401
    [Abstract] [Full Text] [Related]

  • 32. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B, Brune K.
    Pharm Unserer Zeit; 1999 Jan 06; 28(1):21-9. PubMed ID: 10078026
    [No Abstract] [Full Text] [Related]

  • 33. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR, Botting RM.
    Int J Clin Pract; 2000 Jan 06; 54(1):7-9. PubMed ID: 10750251
    [No Abstract] [Full Text] [Related]

  • 34. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis.
    Noreen Y, Ringbom T, Perera P, Danielson H, Bohlin L.
    J Nat Prod; 1998 Jan 06; 61(1):2-7. PubMed ID: 9461646
    [Abstract] [Full Text] [Related]

  • 35. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH, Rao PN, Knaus EE.
    Bioorg Med Chem; 2005 Aug 01; 13(15):4694-703. PubMed ID: 15914011
    [Abstract] [Full Text] [Related]

  • 36. The discovery and function of COX-2.
    Needleman P, Isakson PC.
    J Rheumatol Suppl; 1997 Jul 01; 49():6-8. PubMed ID: 9249644
    [No Abstract] [Full Text] [Related]

  • 37. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
    Wigand R.
    Pharm Unserer Zeit; 2002 Jul 01; 31(2):190-8. PubMed ID: 11977455
    [No Abstract] [Full Text] [Related]

  • 38. Cyclooxygenase-2 inhibitors: promise or peril?
    Mengle-Gaw LJ, Schwartz BD.
    Mediators Inflamm; 2002 Oct 01; 11(5):275-86. PubMed ID: 12467519
    [Abstract] [Full Text] [Related]

  • 39. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
    Warner TD, Mitchell JA.
    Proc Natl Acad Sci U S A; 2002 Oct 15; 99(21):13371-3. PubMed ID: 12374850
    [No Abstract] [Full Text] [Related]

  • 40. Cyclooxygenase (COX) inhibitors: a comparative QSAR study.
    Garg R, Kurup A, Mekapati SB, Hansch C.
    Chem Rev; 2003 Mar 15; 103(3):703-32. PubMed ID: 12630850
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.